Atherosclerosis 150 (2000) 457 – 460
Author index
Volume 150 (2000)
www.elsevier.com/locate/atherosclerosis
Abuja, P.M., see Meraji, S. 150, 403
Akita, H., see Yamada, S. 150, 143
Amarti, A., see Bennani-Kabchi, N. 150, 55
Amouyel, P., see Dallongeville, J. 150, 149
Angelini, G.D., see Dashwood, M.R. 150, 43
Arakawa, K., see Imanaga, Y. 150, 343
Arrol, S., M.I. Mackness, P.N. Durrington, The effects of fatty acids on apolipoprotein B secretion by human hepatoma cells (HEP G2) 150, 255
Arrol, S., M.I. Mackness, P.N. Durrington, Vitamin E supplementa-tion increases the resistance of both LDL and HDL to oxidasupplementa-tion and increases cholesteryl ester transfer activity 150, 129
Aı¨ssa-Benhaddad, A., see Raynaud, E. 150, 365
Aubo´, C., see Sentı´, M. 150, 135
Aviram, M., see Maor, I. 150, 91
Badimon, J.J., see Worthley, S.G. 150, 321
Barbagallo, M., see Paolisso, G. 150, 121
Barbieri, M., see Paolisso, G. 150, 121
Bashar Izzat, M., see Dashwood, M.R. 150, 43
Bell, D.A., see Li, R. 150, 447
Bennani-Kabchi, N., L. Kehel, F. El Bouayadi, H. Fdhil, A. Amarti, A. Saidi, G. Marquie´, New model of atherosclerosis in insulin resistant sand rats: hypercholesterolemia combined with D2 vita-min 150, 55
Black, D.M., see Raal, F.J. 150, 421
Bleich, S., D. Degner, Whole blood folate, homocysteine in serum, and risk of first acute myocardial infarction 150, 441
Boerwinkle, E., see Li, R. 150, 447
Bofilis, E., see Kremastinos, D.T. 150, 81
Bohle, R.M., see Metzger, R. 150, 21
Borgnino, C., see Pauciullo, P. 150, 429
Borst, C., see Pasterkamp, G. 150, 245
Bosch, M., see Sentı´, M. 150, 135
Bray, M., see Li, R. 150, 447
Breithardt, G., see Sindermann, J.R. 150, 443
Breithardt, G., see Sindermann, J.R. 150, 331
Brun, J.-F., see Raynaud, E. 150, 365
Buchholz, D.W., see Wityk, R.J. 150, 389
Casey, S., see George, J. 150, 285
Caslake, M.J., C.J. Packard, K.E. Suckling, S.D. Holmes, P. Chamber-lain, C.H. Macphee, Lipoprotein-associated phospholipase A2,
platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease 150, 413
Chae, I.-H., see Song, J.-M. 150, 309
Chamberlain, P., see Caslake, M.J. 150, 413
Chambless, L.E., see Li, R. 150, 447
Choi, B., see Hwang, J. 150, 275
Choi, Y.-S., see Song, J.-M. 150, 309
Christian Klausen, I., see Højbjerg Gravholt, C. 150, 201
Chumachenko, P., see Metzger, R. 150, 21
Clifton, P.M., M. Noakes, Impaired HDL response to fat in men with coronary artery disease 150, 159
Clifton, P.M., see Heilbronn, L.K. 150, 187
Connor, J.M., see Fowkes, F.G.R. 150, 179
Cooke, A., see Fowkes, F.G.R. 150, 179
Cottel, D., see Dallongeville, J. 150, 149
Crook, M.F., A.C. Newby, K.M. Southgate, Expression of intercellu-lar adhesion molecules in human saphenous veins: effects of inflam-matory cytokines and neointima formation in culture 150, 33
Dallongeville, J., A. Meirhaeghe, D. Cottel, J.-C. Fruchart, P. Amouyel, N. Helbecque, Gender related association between genetic variations ofAPOC-IIIgene and lipid and lipoprotein variables in northern France 150, 149
Danilov, S.M., see Metzger, R. 150, 21
Dashwood, M.R., R. Gibbins, D. Mehta, M. Bashar Izzat, G.D. Angelini, J.Y. Jeremy, Neural reorganisation in porcine vein grafts: a potential role for endothelin-1 150, 43
de Boo, Th., see van den Berkmortel, F.W.P.J. 150, 397
Degner, D., see Bleich, S. 150, 441
de Kleijn, D.P.V., see Pasterkamp, G. 150, 245
Devaraj, S., see Islam, K.N. 150, 217
Durrington, P.N., see Arrol, S. 150, 129
Durrington, P.N., see Arrol, S. 150, 255
Earley, C.J., see Wityk, R.J. 150, 389
El Bouayadi, F., see Bennani-Kabchi, N. 150, 55
Elosua, R., see Sentı´, M. 150, 135
Epstein, A., see Wityk, R.J. 150, 389
Fallon, J.T., see Worthley, S.G. 150, 321
Fan, L., see Sindermann, J.R. 150, 331
Fayad, Z.A., see Worthley, S.G. 150, 321
Fdhil, H., see Bennani-Kabchi, N. 150, 55
Fe´dou, C., see Raynaud, E. 150, 365
Firth, J.C., see Raal, F.J. 150, 421
Fischer Jr., J.R., see Schwertner, H.A. 150, 381
Fowkes, F.G.R., A.J. Lee, C.M. Hau, A. Cooke, J.M. Connor, G.D.O. Lowe, Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh artery study 150, 179
Franke, F.E., see Metzger, R. 150, 21
Friedrich, I., see Winkler, K. 150, 113
Fruchart, J.-C., see Dallongeville, J. 150, 149
Funayama, H., see Hojo, Y. 150, 63
Fuster, V., see Worthley, S.G. 150, 321
Author index6ol.150 (2000) 458
Gardemann, A., M. Harnami, N. Katz, H. Tillmann, W. Haberbosch, The chyrnase A(−1903)G gene polymorphism is not associated with
the risk and extent of coronary heart disease 150, 445
George, J., M. Mulkins, S. Casey, R. Schatzman, E. Sigal, D. Harats, The effects of N-6 polyunsaturated fatty acid supplementation on the lipid composition and atherogenesis in mouse models of atheroscle-rosis 150, 285
Gey, K.F., see Meraji, S. 150, 403 Gibbins, R., see Dashwood, M.R. 150, 43
Gierens, H., see Winkler, K. 150, 113 Giordano, M., see Paolisso, G. 150, 121
Greilberger, J., see Wang, X. 150, 357
Groot, P.H.E., see Van Eck, M. 150, 71
Grundy, S.M., see Islam, K.N. 150, 217
Haberbosch, W., see Gardemann, A. 150, 445
Harats, D., see George, J. 150, 285 Harnami, M., see Gardemann, A. 150, 445
Hashimoto, K., see Suehiro, T. 150, 295 Hau, C.M., see Fowkes, F.G.R. 150, 179
Hayek, T., see Maor, I. 150, 91
Hayn, M., see Meraji, S. 150, 403
Hebel, J.R., see Wityk, R.J. 150, 389
Heilbronn, L.K., M. Noakes, A.M. Morris, K.L. Kind, P.M. Clifton, 360His polymorphism of the apolipoproteinA-IV gene and plasma lipid response to energy restricted diets in overweight subjects 150, 187
Heinonen, T.M., see Raal, F.J. 150, 421 Heiss, G., see Li, R. 150, 447
Helbecque, N., see Dallongeville, J. 150, 149
Helft, G., see Worthley, S.G. 150, 321
Herijgers, N., see Van Eck, M. 150, 71
Hijnen, D.J., see Pasterkamp, G. 150, 245 Hirata, K.-i., see Yamada, S. 150, 143
Hirsh, M., see Maor, I. 150, 91
Højbjerg Gravholt, C., I. Christian Klausen, J. Weeke, J. Sandahl Christiansen, Lp(a) and lipids in adult Turner’s syndrome: impact of treatment with 17b-estradiol and norethisterone 150, 201
Hodis, H.N., see Hwang, J. 150, 275
Hodis, H.N., see Mack, W.J. 150, 371
Hojo, Y., U. Ikeda, Y. Maeda, M. Takahashi, T. Takizawa, M. Okada, H. Funayama, K. Shimada, Interaction between human monocytes and vascular smooth muscle cells induces vascular endothelial growth factor expression 150, 63
Holmes, S.D., see Caslake, M.J. 150, 413
Hoogerbrugge, P.M., see Van Eck, M. 150, 71 Horiuchi, S., see Imanaga, Y. 150, 343
Hwang, J., H. Peterson, H.N. Hodis, B. Choi, A. Sevanian, Ascorbic acid enhances 17b-estradiol-mediated inhibition of oxidized low density lipoprotein formation 150, 275
Iancu, T.C., see Maor, I. 150, 91
Ichihara, S., see Yamada, Y. 150, 209 Ikeda, U., see Hojo, Y. 150, 63
Ikeda, Y., see Suehiro, T. 150, 295 Ikenoue, N., see Wakatsuki, A. 150, 103
Iliodromitis, E.K., see Kremastinos, D.T. 150, 81
Illingworth, D.R., see Raal, F.J. 150, 421
Imaizumi, T., see Yamada, Y. 150, 209
Imanaga, Y., N. Sakata, S. Takebayashi, A. Matsunaga, J. Sasaki, K. Arakawa, R. Nagai, S. Horiuchi, H. Itabe, T. Takano, In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques 150, 343
Inoue, M., see Suehiro, T. 150, 295 Ishida, T., see Yamada, S. 150, 143
Islam, K.N., D. O’Byrne, S. Devaraj, B. Palmer, S.M. Grundy, I. Jialal, Alpha-tocopherol supplementation decreases the oxidative suscepti-bility of LDL in renal failure patients on dialysis therapy 150, 217
Itabe, H., see Imanaga, Y. 150, 343
Ito, K., see Yamada, S. 150, 143
Jenner, J.L., see Wityk, R.J. 150, 389
Jeremy, J.Y., see Dashwood, M.R. 150, 43
Jialal, I., see Islam, K.N. 150, 217
Johnson, C.J., see Wityk, R.J. 150, 389
Ju¨rgens, G., see Wang, X. 150, 357
Kaklamanis, L., see Kremastinos, D.T. 150, 81
Kanazawa, K., see Yamada, S. 150, 143
Kaprio, J., U.M. Kujala, M. Koskenvuo, S. Sarna, Physical activity and other risk factors in male twin-pairs discordant for coronary heart disease 150, 193
Karavolias, G.K., see Kremastinos, D.T. 150, 81 Katz, N., see Gardemann, A. 150, 445
Kawashima, S., see Yamada, S. 150, 143 Kehel, L., see Bennani-Kabchi, N. 150, 55 Kim, H.-S., see Song, J.-M. 150, 309 Kind, K.L., see Heilbronn, L.K. 150, 187 Kittner, S.J., see Wityk, R.J. 150, 389 Klima, B., see Winkler, K. 150, 113 Klu¨ßendorf, D., see Siegel, G. 150, 437 Koskenvuo, M., see Kaprio, J. 150, 193 Ko¨ster, W., see Winkler, K. 150, 113 Kostner, G.M., see Meraji, S. 150, 403 Kotze, M.J., see Raal, F.J. 150, 421
Kremastinos, D.T., E. Bofilis, G.K. Karavolias, A. Papalois, L. Kaklamanis, E.K. Iliodromitis, Preconditioning limits myocardial infarct size in hypercholesterolemic rabbits 150, 81
Kujala, U.M., see Kaprio, J. 150, 193 Kumon, Y., see Suehiro, T. 150, 295
LaBree, L., see Mack, W.J. 150, 371
Lee, A.J., see Fowkes, F.G.R. 150, 179
Lee, M.-M., see Song, J.-M. 150, 309
Lee, Y.-W., see Song, J.-M. 150, 309
Lichtenstein, A.H., U.S. Schwab, Relationship of dietary fat to glucose metabolism 150, 227
Li, R., E. Boerwinkle, A.F. Olshan, L.E. Chambless, J.S. Pankow, H.A. Tyroler, M. Bray, G.S. Pittman, D.A. Bell, G. Heiss, Erratum to ‘Glutathione S-transferase genotype as a susceptibility factor in smoking-related coronary heart disease’ 150, 447
Liu, C.-H., see Mack, W.J. 150, 371
Liu, C.-R., see Mack, W.J. 150, 371
Lowe, G.D.O., see Fowkes, F.G.R. 150, 179
Mackness, M.I., see Arrol, S. 150, 129
Mackness, M.I., see Arrol, S. 150, 255
Macko, R.F., see Wityk, R.J. 150, 389
Mack, W.J., L. LaBree, C.-R. Liu, C.-H. Liu, R.H. Selzer, H.N. Hodis, Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography 150, 371
Macphee, C.H., see Caslake, M.J. 150, 413
Maeda, Y., see Hojo, Y. 150, 63
Malmstro¨m, R., see Mero, N. 150, 167
Mancini, M., see Pauciullo, P. 150, 429
Maor, I., T. Hayek, M. Hirsh, T.C. Iancu, M. Aviram, Macrophage-re-leased proteoglycans enhance LDL aggregation: studies in aorta from apolipoprotein E-deficient mice 150, 91
Marais, A.D., see Raal, F.J. 150, 421
March, K.L., see Sindermann, J.R. 150, 331
Mariani, M., see Pauciullo, P. 150, 429
Author index6ol.150 (2000) 459
Marrugat, J., see Sentı´, M. 150, 135
Martin, K.R., D. Wu, M. Meydani, The effect of carotenoids on the expression of cell surface adhesion molecules and binding of mono-cytes to human aortic endothelial cells 150, 265
Martins, I.J., R. Vermeulen, T.G. Redgrave, Relative roles of mito-chondrial and peroxisomal fatty acid oxidation in the metabolism of chylomicron remnants in rats and mice as assessed by a stable-isotope breath test 150, 13
Ma¨rz, W., see Winkler, K. 150, 113
Masia`, R., see Sentı´, M. 150, 135
Matsunaga, A., see Imanaga, Y. 150, 343
McCarter, R.J., see Wityk, R.J. 150, 389
Mehta, D., see Dashwood, M.R. 150, 43
Meirhaeghe, A., see Dallongeville, J. 150, 149
Meraji, S., P.M. Abuja, M. Hayn, G.M. Kostner, R. Morris, S. Oraii, F. Tatzber, W. Wonisch, R. Zechner, K.F. Gey, Relationship between classic risk factors, plasma antioxidants and indicators of oxidant stress in angina pectoris (AP) in Tehran 150, 403 Mercier, J., see Raynaud, E. 150, 365
Mero, N., R. Malmstro¨m, G. Steiner, M.-R. Taskinen, M. Syva¨nne, Postprandial metabolism of apolipoprotein B-48- and B-100-con-taining particles in type 2 diabetes mellitus: relations to angiograph-ically verified severity of coronary artery disease 150, 167 Metzger, R., R.M. Bohle, P. Chumachenko, S.M. Danilov, F.E.
Franke, CD143 in the development of atherosclerosis 150, 21 Meydani, M., see Martin, K.R. 150, 265
Morris, A.M., see Heilbronn, L.K. 150, 187 Morris, R., see Meraji, S. 150, 403 Mulkins, M., see George, J. 150, 285 Mu¨ller, J.G., see Sindermann, J.R. 150, 331 Nagai, R., see Imanaga, Y. 150, 343 Nakamura, T., see Suehiro, T. 150, 295 Newby, A.C., see Crook, M.F. 150, 33 Noakes, M., see Clifton, P.M. 150, 159
Noakes, M., see Heilbronn, L.K. 150, 187
Nuber, C., see Winkler, K. 150, 113
O’Byrne, D., see Islam, K.N. 150, 217
Oh, B.-H., see Song, J.-M. 150, 309
Okada, M., see Hojo, Y. 150, 63
Okatani, Y., see Wakatsuki, A. 150, 103
Oliver, M.F., Pioneer research in Britain into atherosclerosis and coronary heart disease — an historical review 150, 1
Olshan, A.F., see Li, R. 150, 447
Oraii, S., see Meraji, S. 150, 403
Osende, J.I., see Worthley, S.G. 150, 321
Packard, C.J., see Caslake, M.J. 150, 413
Palmer, B., see Islam, K.N. 150, 217
Pankow, J.S., see Li, R. 150, 447
Paoletti, R., see Pauciullo, P. 150, 429
Paolisso, G., M. Barbagallo, G. Petrella, E. Ragno, M. Barbieri, M. Giordano, M. Varricchio, Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients 150, 121
Papalois, A., see Kremastinos, D.T. 150, 81
Pappu, A.S., see Raal, F.J. 150, 421
Park, Y.-B., see Song, J.-M. 150, 309
Pasterkamp, G., A.H. Schoneveld, D.J. Hijnen, D.P.V. de Kleijn, H. Teepen, A.C. van der Wal, C. Borst, Atherosclerotic arterial remod-eling and the localization of macrophages and matrix metallo-proteases 1, 2 and 9 in the human coronary artery 150, 245
Pauciullo, P., C. Borgnino, R. Paoletti, M. Mariani, M. Mancini, Efficacy and safety of a combination of fluvastatin and bezafibrate in patients with mixed hyperlipidaemia (FACT study) 150, 429
Pearce, N.J., see Van Eck, M. 150, 71
Pe´rez-Martin, A., see Raynaud, E. 150, 365
Peterson, H., see Hwang, J. 150, 275 Petrella, G., see Paolisso, G. 150, 121
Pilcher, G.J., see Raal, F.J. 150, 421
Pittman, G.S., see Li, R. 150, 447
Price, T.R., see Wityk, R.J. 150, 389
Raal, F.J., A.S. Pappu, D.R. Illingworth, G.J. Pilcher, A.D. Marais, J.C. Firth, M.J. Kotze, T.M. Heinonen, D.M. Black, Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hyper-cholesterolaemia 150, 421
Ragno, E., see Paolisso, G. 150, 121
Raynaud, E., A. Pe´rez-Martin, J.-F. Brun, A. Aı¨ssa-Benhaddad, C. Fe´dou, J. Mercier, Relationships between fibrinogen and insulin resistance 150, 365
Razum, O., H. Zeeb, Risk of coronary heart disease among Turkish migrants to Germany: further epidemiological evidence 150, 439
Redgrave, T.G., see Martins, I.J. 150, 13
Ren, S., see Zhang, J. 150, 299 Rhee, M.-Y., see Song, J.-M. 150, 309
Rodriguez, O.J., see Worthley, S.G. 150, 321
Roque´, M., see Worthley, S.G. 150, 321
Saidi, A., see Bennani-Kabchi, N. 150, 55
Sakata, N., see Imanaga, Y. 150, 343
Sandahl Christiansen, J., see Højbjerg Gravholt, C. 150, 201
Sarna, S., see Kaprio, J. 150, 193
Sasaki, J., see Imanaga, Y. 150, 343 Satoh, K., see Yamada, Y. 150, 209
Schaefer, E.J., see Wityk, R.J. 150, 389
Schaefer, J.R., see Winkler, K. 150, 113
Scharnagl, H., see Winkler, K. 150, 113 Schatzman, R., see George, J. 150, 285
Schmidt, A., see Sindermann, J.R. 150, 443
Schmidt, A., see Sindermann, J.R. 150, 331
Schoneveld, A.H., see Pasterkamp, G. 150, 245 Schwab, U.S., see Lichtenstein, A.H. 150, 227
Schwertner, H.A., J.R. Fischer Jr., Comparison of various lipid, lipoprotein, and bilirubin combinations as risk factors for predicting coronary artery disease 150, 381
Selzer, R.H., see Mack, W.J. 150, 371
Sentı´, M., M. Bosch, C. Aubo´, R. Elosua, R. Masia`, J. Marrugat, Relationship of abdominal adiposity and dyslipemic status in women with a common mutation in the lipoprotein lipase gene 150, 135 Sevanian, A., see Hwang, J. 150, 275
Shen, G.X., see Zhang, J. 150, 299
Shiinoki, T., see Suehiro, T. 150, 295
Shimada, K., see Hojo, Y. 150, 63
Shindo, M., see Suehiro, T. 150, 295 Shinnar, M., see Worthley, S.G. 150, 321
Siegel, G., D. Klu¨ßendorf, The anti-atheroslerotic effect of Allium sati6um: Statistics re-evaluated 150, 437
Sigal, E., see George, J. 150, 285
Sindermann, J.R., A. Schmidt, G. Breithardt, Upregulation of the interleukin-8 system in hypercholesterolemic patients. Does inhibi-tion of the mevalonate pathway lower interleukin-8 levels in the vessel wall? 150, 443
Sindermann, J.R., L. Fan, K.A. Weigel, D. Troyer, J.G. Mu¨ller, A. Schmidt, K.L. March, G. Breithardt, Differences in the effects of HMG-CoA reductase inhibitors on proliferation and viability of smooth muscle cells in culture 150, 331
Sloan, M.A., see Wityk, R.J. 150, 389
Smilde, T.J., see van den Berkmortel, F.W.P.J. 150, 397
Sohn, D.-W., see Song, J.-M. 150, 309
Author index6ol.150 (2000) 460
Soufi, M., see Winkler, K. 150, 113
Southgate, K.M., see Crook, M.F. 150, 33
Steiner, G., see Mero, N. 150, 167
Stern, B.J., see Wityk, R.J. 150, 389
Stolley, P.D., see Wityk, R.J. 150, 389 Suckling, K.E., see Caslake, M.J. 150, 413
Suehiro, T., T. Nakamura, M. Inoue, T. Shiinoki, Y. Ikeda, Y. Kumon, M. Shindo, H. Tanaka, K. Hashimoto, A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression 150, 295
Syva¨nne, M., see Mero, N. 150, 167
Takahashi, M., see Hojo, Y. 150, 63
Takano, T., see Imanaga, Y. 150, 343
Takebayashi, S., see Imanaga, Y. 150, 343
Takizawa, T., see Hojo, Y. 150, 63
Tanaka, H., see Suehiro, T. 150, 295
Taskinen, M.-R., see Mero, N. 150, 167
Tatzber, F., see Meraji, S. 150, 403
Teepen, H., see Pasterkamp, G. 150, 245
Thien, Th., see van den Berkmortel, F.W.P.J. 150, 397
Tillmann, H., see Gardemann, A. 150, 445 Troyer, D., see Sindermann, J.R. 150, 331 Tyroler, H.A., see Li, R. 150, 447
Van Berkel, T.J.C., see Van Eck, M. 150, 71
van den Berkmortel, F.W.P.J., T.J. Smilde, H. Wollersheim, H. van Langen, T. de Boo, T. Thien, Intima – media thickness of peripheral arteries in asymptomatic cigarette smokers 150, 397
van der Wal, A.C., see Pasterkamp, G. 150, 245
Van Eck, M., N. Herijgers, M. Vidgeon-Hart, N.J. Pearce, P.M. Hoogerbrugge, P.H.E. Groot, T.J.C. Van Berkel, Accelerated atherosclerosis in C57Bl/6 mice transplanted with ApoE-deficient bone marrow 150, 71
van Langen, H., see van den Berkmortel, F.W.P.J. 150, 397
Varricchio, M., see Paolisso, G. 150, 121
Verhallen, P., see Worthley, S.G. 150, 321
Vermeulen, R., see Martins, I.J. 150, 13
Vidgeon-Hart, M., see Van Eck, M. 150, 71
Wakatsuki, A., Y. Okatani, N. Ikenoue, Effects of combination therapy with estrogen plus simvastatin on lipoprotein metabolism in postmenopausal women with type IIa hypercholesterolemia 150,
103
Wang, X., J. Greilberger, G. Ju¨rgens, Calcium and lipoprotein lipase synergistically enhance the binding and uptake of native and oxidized LDL in mouse peritoneal macrophages 150, 357
Weeke, J., see Højbjerg Gravholt, C. 150, 201
Weigel, K.A., see Sindermann, J.R. 150, 331 Wieland, H., see Winkler, K. 150, 113
Winkler, K., J.R. Schaefer, B. Klima, C. Nuber, I. Friedrich, W. Ko¨ster, H. Gierens, H. Scharnagl, M. Soufi, H. Wieland, W. Ma¨rz, HDL steady state levels are not affected, but HDL apoA-I turnover is enhanced by Lifibrol in patients with hypercholesterolemia and mixed hyperlipidemia 150, 113
Wityk, R.J., S.J. Kittner, J.L. Jenner, J.R. Hebel, A. Epstein, M.A. Wozniak, P.D. Stolley, B.J. Stern, M.A. Sloan, T.R. Price, R.J. McCarter, R.F. Macko, C.J. Johnson, C.J. Earley, D.W. Buchholz, E.J. Schaefer, Lipoprotein (a) and the risk of ischemic stroke in young women 150, 389
Wollersheim, H., see van den Berkmortel, F.W.P.J. 150, 397
Wonisch, W., see Meraji, S. 150, 403
Worthley, S.G., G. Helft, V. Fuster, Z.A. Fayad, J.T. Fallon, J.I. Osende, M. Roque´, M. Shinnar, A.G. Zaman, O.J. Rodriguez, P. Verhallen, J.J. Badimon, High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model 150, 321
Wozniak, M.A., see Wityk, R.J. 150, 389 Wu, D., see Martin, K.R. 150, 265
Yamada, S., H. Akita, K. Kanazawa, T. Ishida, K.-i. Hirata, K. Ito, S. Kawashima, M. Yokoyama, T102C polymorphism of the sero-tonin (5-HT) 2A receptor gene in patients with non-fatal acute myocardial infarction 150, 143
Yamada, Y., H. Yoshida, S. Ichihara, T. Imaizumi, K. Satoh, M. Yokota, Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population 150, 209
Yokota, M., see Yamada, Y. 150, 209
Yokoyama, M., see Yamada, S. 150, 143
Yoshida, H., see Yamada, Y. 150, 209
Zaman, A.G., see Worthley, S.G. 150, 321 Zechner, R., see Meraji, S. 150, 403 Zeeb, H., see Razum, O. 150, 439
Zhang, J., S. Ren, G.X. Shen, Glycation amplifies lipoprotein(a)-in-duced alterations in the generation of fibrinolytic regulators from human vascular endothelial cells 150, 299
